Scholarlink

Introduction <p>Radiological interventions in Budd-Chiari syndrome (BCS) include anatomical recanalization&#xa0;of the hepatic vein (HV), inferior vena cava (IVC) angioplasty and stenting. In case of technical difficulty and anatomical non-feasibility, an ultrasound-guided direct intrahepatic portosystemic shunt (DIPSS) is created. We aimed at evaluating the outcome of patients managed with DIPSS and comparing it with anatomical recanalization.</p> Methods <p>We retrieved the data of patients with BCS managed at our institution between 2011 and 2021. Safety, efficacy and long-term outcomes were assessed and compared between radiological interventions.</p> Results <p>Total 236 patients with BCS underwent radiological intervention in the study period. As many as&#xa0;96 patients were excluded&#xa0;and 140 patients were included in the final analysis. The majority were males (F:M = 54:86). The median age at the time of diagnosis was 30&#xa0;years (interquartile range: 25–37&#xa0;years). The median follow-up period was 58 (14–72) months. On imaging, 53% (74) patients had combined HV and IVC block followed by isolated HV block in 54 patients (38.5%) and isolated IVC block in 12 patients (8.5%). As many as&#xa0;32 patients were managed by DIPSS. Among others, 56 patients underwent IVC angioplasty with HV stenting and 30 required HV angioplasty and stenting. DIPSS had a comparable technical success rate (100% vs. 98.2% vs. 96%, respectively <i>p</i> &gt; 0.5). However, the median stent patency was higher in the DIPSS group (72 [48–96] months) compared to IVC angioplasty and HV stenting (46 [36–60] months; <i>p</i> = 0.02) and HV angioplasty-stenting (42 [30–48] months; <i>p</i> = 0.04)&#xa0;groups. They had similar re-thrombosis rates (28%, 34% and 21%, respectively; <i>p</i> &gt; 0.05). Overall complications were rare (3.5%) and no patient in the DIPSS group had adverse events.</p> Conclusion <p>DIPSS is a safe and effective salvage procedure with an excellent long-term outcome in patients with BCS. It has a longer median stent patency compared to the anatomical recanalization group.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Comparison of direct intrahepatic portosystemic shunt and other major radiological interventions in patients with Budd-Chiari syndrome

  • 期刊论文

  • 发表日期：

    2025年3月7日

查看全文
  • Sayan Malakar,
  • Nishant Shah,
  • Umair Shamsul Hoda,
  • Avinash D. Gautam,
  • Rajanikant R. Yadav,
  • Srikanth Kothalkar,
  • Rahul Jangra,
  • Gaurav Pandey,
  • Akash Roy,
  • Praveer Rai,
  • Samir Mohindra,
  • Uday C. Ghoshal

摘要

Introduction

Radiological interventions in Budd-Chiari syndrome (BCS) include anatomical recanalization of the hepatic vein (HV), inferior vena cava (IVC) angioplasty and stenting. In case of technical difficulty and anatomical non-feasibility, an ultrasound-guided direct intrahepatic portosystemic shunt (DIPSS) is created. We aimed at evaluating the outcome of patients managed with DIPSS and comparing it with anatomical recanalization.

Methods

We retrieved the data of patients with BCS managed at our institution between 2011 and 2021. Safety, efficacy and long-term outcomes were assessed and compared between radiological interventions.

Results

Total 236 patients with BCS underwent radiological intervention in the study period. As many as 96 patients were excluded and 140 patients were included in the final analysis. The majority were males (F:M = 54:86). The median age at the time of diagnosis was 30 years (interquartile range: 25–37 years). The median follow-up period was 58 (14–72) months. On imaging, 53% (74) patients had combined HV and IVC block followed by isolated HV block in 54 patients (38.5%) and isolated IVC block in 12 patients (8.5%). As many as 32 patients were managed by DIPSS. Among others, 56 patients underwent IVC angioplasty with HV stenting and 30 required HV angioplasty and stenting. DIPSS had a comparable technical success rate (100% vs. 98.2% vs. 96%, respectively p > 0.5). However, the median stent patency was higher in the DIPSS group (72 [48–96] months) compared to IVC angioplasty and HV stenting (46 [36–60] months; p = 0.02) and HV angioplasty-stenting (42 [30–48] months; p = 0.04) groups. They had similar re-thrombosis rates (28%, 34% and 21%, respectively; p > 0.05). Overall complications were rare (3.5%) and no patient in the DIPSS group had adverse events.

Conclusion

DIPSS is a safe and effective salvage procedure with an excellent long-term outcome in patients with BCS. It has a longer median stent patency compared to the anatomical recanalization group.

Graphical abstract